News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rodgers Richard J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| Rodgers Richard J (Director) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 18,494 shares
@ $0
Granted 49,237 options to buy
@ $3.92, valued at
$193k
|
|
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2023 |
4
| Rodgers Richard J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 20,822 shares
@ $0 |
|
| 11/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/04/2022 |
4
| Rodgers Richard J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Exercised (in-or-at-the-money) 3,148 options to buy
@ $0.0001, valued at
$0.3 |
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Rodgers Richard J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 4,629 shares
@ $0 |
|
| 01/05/2022 |
4
| Rodgers Richard J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 4,021 shares
@ $0 |
|
| 10/04/2021 |
4
| Rodgers Richard J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 2,912 shares
@ $0 |
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/25/2020 |
4
| Rodgers Richard J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Bought 17,730 shares
@ $0
Bought 26,789 options to buy
@ $0
Bought 3,148 options to buy
@ $0.0001, valued at
$0.3 |
|
| 11/13/2020 |
4
| Rodgers Richard J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 50,000 options to buy
@ $4.05, valued at
$202.5k
|
|
| 11/09/2020 |
4
| Rodgers Richard J (Director) has filed a Form 4 on Ocuphire Pharma, Inc.|
Txns:
| Granted 5,910 shares
@ $0 |
|
| 06/11/2020 |
4
| Rodgers Richard J (Director) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 9,233 shares
@ $0
Granted 23,500 options to buy
@ $7.31, valued at
$171.8k
|
|
| 06/17/2019 |
4
| Rodgers Richard J (Director) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 24,635 shares
@ $0
Granted 50,000 options to buy
@ $2.74, valued at
$137k
|
|
| 06/07/2019 |
4
| Rodgers Richard J (Director) has filed a Form 4 on REXAHN PHARMACEUTICALS, INC.|
Txns:
| Granted 3,537 options to buy
@ $5.23, valued at
$18.5k
|
|
| 06/29/2018 |
4
| Rodgers Richard J (Director) has filed a Form 4 on REXAHN PHARMACEUTICALS, INC.|
Txns:
| Granted 39,742 options to buy
@ $1.46, valued at
$58k
|
|
| 06/15/2018 |
4
| Rodgers Richard J (Director) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 16,749 shares
@ $0
Granted 15,000 options to buy
@ $4.03, valued at
$60.5k
|
|
| 06/09/2017 |
4
| Rodgers Richard J (Director) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 15,697 shares
@ $0
Granted 15,000 options to buy
@ $4.3, valued at
$64.5k
|
|
| 04/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/06/2016 |
4
| Rodgers Richard J (Director) has filed a Form 4 on ARDELYX, INC. |
| 03/08/2013 |
4
| Rodgers Richard J (Executive VP & CFO) has filed a Form 4 on TESARO, Inc. |
| 07/06/2012 |
4
| Rodgers Richard J (Exec. Vice President & CFO) has filed a Form 4 on TESARO, Inc. |
| 07/15/2009 |
4
| Rodgers Richard J (Senior Vice President and CFO) has filed a Form 4 on Abraxis BioScience, Inc. |
|
|